CRL Stock May Benefit From New Neuroscience Research Collaboration

Charles River Laboratories International, Inc. (CRL) and Insightec announced a five-year strategic collaboration to advance the applications of focused ultrasound (FUS) for drug discovery and preclinical development of therapeutics in neuroscience. Under the partnership, Charles River's clients will gain access to Insightec's novel low-frequency ultrasound platform, which non-invasively disrupts the blood-brain barrier, enabling drugs to be delivered to targeted brain areas. The latest development is expect ...